Abrdn PLC Medpace Holdings, Inc. Transaction History

Abrdn PLC

$50 Billion
Q1 2024

A detailed history of Abrdn PLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Abrdn PLC holds 87,531 shares of MEDP stock, worth $35.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

87,531

Previous 17,483 400.66%

Holding current value

$35.4 Million

Previous $5.36 Million 560.1%

% of portfolio

0.07%

Previous 0.01%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$284.87 - $413.31 $20 Million - $29 Million	70,048 Added 400.66%	87,531 $35.4 Million
Q4 2023 Jan 31, 2024	BUY	$227.52 - $312.68 $3.98 Million - $5.47 Million	17,483 New	17,483 $5.36 Million
Q2 2022 Aug 05, 2022	SELL	$130.2 - $168.03 $1.04 Million - $1.34 Million	-8,000 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$138.87 - $214.31 $11,526 - $17,787	-83 Reduced 1.03%	8,000 $1.31 Million
Q4 2021 Feb 08, 2022	SELL	$182.74 - $227.9 $45.2 Million - $56.3 Million	-247,203 Reduced 96.83%	8,083 $1.76 Million

Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $4.27 Million - $4.98 Million	-25,105 Reduced 8.95%	255,286 $48.3 Million
Q2 2021 Aug 10, 2021	SELL	$158.62 - $194.3 $15.9 Million - $19.4 Million	-99,993 Reduced 26.29%	280,391 $49.6 Million
Q1 2021 May 06, 2021	BUY	$132.02 - $168.26 $24.9 Million - $31.8 Million	188,906 Added 98.66%	380,384 $62.4 Million
Q4 2020 Feb 10, 2021	BUY	$109.38 - $149.19 $20.9 Million - $28.6 Million	191,478 New	191,478 $26.7 Million

Others Institutions Holding MEDP

# of Institutions

622

Shares Held

25.1M

Call Options Held

154K

Put Options Held

117K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account